scispace - formally typeset
L

Leander Van Neste

Researcher at Maastricht University

Publications -  58
Citations -  12557

Leander Van Neste is an academic researcher from Maastricht University. The author has contributed to research in topics: DNA methylation & Cancer. The author has an hindex of 35, co-authored 57 publications receiving 11165 citations. Previous affiliations of Leander Van Neste include Ghent University & Maastricht University Medical Centre.

Papers
More filters
Journal ArticleDOI

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger E. McLendon, +233 more
- 23 Oct 2008 - 
TL;DR: The interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated gliobeasts, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.
Journal ArticleDOI

Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands

TL;DR: It is demonstrated that inducing cellular oxidative stress by hydrogen peroxide treatment recruits DNA methyltransferase 1 (DNMT1) to damaged chromatin, forming a silencing complex that may explain cancer-specific aberrant DNA methylation and transcriptional silencing.
Journal ArticleDOI

Promoter CpG Methylation Contributes to ES Cell Gene Regulation in Parallel with Oct4/Nanog, PcG Complex, and Histone H3 K4/K27 Trimethylation

TL;DR: In this paper, the authors report a genome-wide mapping of DNA methylation patterns at proximal promoter regions in mouse embryonic stem (mES) cells, finding that the only marker of this group present on ∼30% of genes, many of which are silenced in mES cells.
Journal ArticleDOI

Analysis of DNA methylation in cancer: location revisited

TL;DR: The authors describe the importance of considering the genomic locations examined in determining the diagnostic or prognostic relevance of putative DNA methylation-based biomarkers.